Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Determination of Hecogenin in Mouse Blood by UPLC-MS/MS and Applied to a Pharmacokinetic Study.

Created on 14 Sep 2026

Authors

Yujie Hu, Lei Zhu, Xueying Xiang, Tao Zou, Congcong Wen, Qiong Duan

Published in

Biomedical chromatography : BMC. Volume 40. Issue 10. Pages e70618.

Abstract

Hecogenin, a steroidal sapogenin from agave plants, exhibits anti-inflammatory, anti-tumor, gastroprotective, and diuretic activities. A sensitive ultraperformance liquid chromatography-tandem mass spectrometry (UPLC-MS/MS) method was developed and validated for quantifying hecogenin in mouse whole blood using swertisin as internal standard. Protein precipitation with acetonitrile enabled simple pretreatment of only 20-μL blood samples. Separation was achieved on a BEH C18 column with gradient elution, and detection was performed via multiple reaction monitoring in positive electrospray ionization mode. The assay was linear over 1-2000 ng/mL (r = 0.9988), with a lower limit of quantification of 1 ng/mL. Intra- and interday precision (RSD) were below 11% and 12%, respectively, and accuracy ranged from 93.2% to 110.4%. Matrix effects were negligible, and extraction recovery was 87.5%-91.2%. The validated method was applied to a pharmacokinetic study in male ICR mice following intravenous (5 mg/kg) and oral (10, 20 mg/kg) administration. Noncompartmental analysis revealed low oral absolute bioavailability (10.8%-12.4%).

PMID:
42733000
Bibliographic data and abstract were imported from PubMed on 14 Sep 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 6
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement